Polsinelli Podcasts - FDA Denies Amgen Citizen Petition in Biosimilar Dispute
Mylan N.V. and Biocon Ltd. recently announced that the European Medicines Agency has accepted Mylan’s Marketing Authorization Application for a proposed biosimilar version of Amgen’s Neulasta (pegfilgrastim). In Europe,...more